A neoplasm is an abnormal mass of tissue that forms when cells grow and divide more than they should, or when old cells fail to die on schedule. The term covers a wide spectrum, from harmless growths like skin moles to life-threatening cancers. In 2022 alone, an estimated 20 million new malignant neoplasms were diagnosed worldwide, with 9.7 million cancer-related deaths. But many neoplasms never become dangerous, and understanding the differences is key to making sense of a diagnosis.
How Neoplasms Form
Your body constantly produces new cells and retires old ones through a tightly controlled cycle. Normally, when a cell’s DNA becomes damaged, built-in checkpoints pause division so the damage can be repaired, or the cell is programmed to self-destruct. A neoplasm develops when those safety mechanisms break down.
Two categories of genes play central roles. The first are tumor suppressor genes, which act like brakes on cell division. When one of these genes (like the well-known p53 gene) is mutated, cells with damaged DNA keep dividing instead of stopping or dying. The second category, called proto-oncogenes, normally help regulate healthy growth. When mutated, they become stuck in the “on” position, pushing cells to multiply far faster than they should. Cancer typically isn’t the result of a single genetic mistake. It usually takes multiple mutations across several of these regulatory genes before a cell line becomes truly out of control.
Benign, Premalignant, and Malignant
Not all neoplasms behave the same way. The critical distinction is whether the growth stays put or spreads.
- Benign neoplasms do not invade surrounding tissues or travel to other parts of the body. They can still grow large enough to cause problems by pressing on nerves, blood vessels, or organs, but they lack the cellular machinery to spread. Common examples include uterine fibroids, lipomas (fatty lumps under the skin), and many types of polyps.
- Premalignant (in situ) neoplasms sit in a gray zone. The cells look abnormal under a microscope, sometimes identical to cancer cells, but they haven’t yet broken through the boundary layer (called the basement membrane) that separates them from deeper tissue. Carcinoma in situ is classified as stage 0 disease. It may eventually become invasive, which is why doctors typically recommend removing or closely monitoring it.
- Malignant neoplasms are cancers. They invade through the basement membrane and can spread to distant organs through the bloodstream, the lymphatic system, or by seeding into body cavities. This ability to metastasize is what makes malignant neoplasms dangerous.
Where Neoplasms Are Most Common
Neoplasms can develop in virtually any tissue, but certain sites account for the majority of malignant cases. The most frequently diagnosed cancers worldwide are breast, prostate, lung, colorectal, and skin cancers. Benign neoplasms are even more widespread. Thyroid nodules, for instance, are found in up to half of all adults on ultrasound, and the vast majority are harmless.
How Neoplasms Are Named
Medical names for neoplasms follow a pattern that tells you two things: what tissue the growth came from and whether it’s benignant or malignant. Benign growths typically end in “-oma,” as in adenoma (a benign growth of gland tissue) or lipoma (a benign growth of fat cells).
Malignant neoplasms get more specific labels. A carcinoma is a cancer that arises in epithelial tissue, the cells lining your skin, organs, and glands. This is the most common cancer category. A sarcoma originates in connective and supportive tissues like bone, cartilage, muscle, or fat. So if you see “osteosarcoma” on a report, it means a malignant tumor of bone. These naming conventions help doctors communicate precisely about what kind of growth they’re dealing with and where it started.
How Neoplasms Are Diagnosed
There is no single test that can identify a neoplasm or determine whether it’s dangerous. Diagnosis usually unfolds in stages, starting with a physical exam and medical history, then moving to imaging and, when needed, a biopsy.
Imaging
Imaging tests create pictures of what’s happening inside your body. CT scans and MRIs can reveal tumors and show their size, shape, and location. Both sometimes use a contrast dye injected into a vein to make abnormal tissue stand out more clearly. PET scans work differently: you receive an injection of radioactive glucose, and because cancer cells tend to consume more sugar than normal cells, they light up on the scan. Bone scans use a similar tracer approach to find abnormal activity in the skeleton. Each method has strengths, and doctors often combine more than one to get a complete picture.
Biopsy
A biopsy is often the only way to confirm whether a neoplasm is benign or malignant. A pathologist examines the removed tissue under a microscope and runs additional tests on the cells. There are several ways to get that tissue sample. Needle biopsies use a thin or thick needle to withdraw cells and are common for breast, prostate, and liver growths. Endoscopic biopsies use a thin, lighted tube inserted through a natural opening (the mouth for lung tissue, the anus for colon tissue) to reach and snip a sample. Surgical biopsies remove either the entire growth (excisional) or just a portion of it (incisional), depending on the situation. The method chosen depends on the tumor’s location, size, and how accessible it is.
What Happens After Diagnosis
What comes next depends entirely on the type of neoplasm. Many benign growths require no treatment at all, just periodic monitoring to make sure they aren’t growing or pressing on something important. If a benign neoplasm does cause symptoms, such as pain or compression of nearby structures, surgical removal usually resolves the problem.
Premalignant neoplasms are typically removed or treated before they have a chance to become invasive. For example, a precancerous polyp found during a colonoscopy is usually snipped out during the same procedure.
Malignant neoplasms require more intensive treatment plans that vary by cancer type, stage, and location. The overall outlook for cancer has improved substantially. As of 2022, an estimated 53.5 million people were alive within five years of a cancer diagnosis globally, reflecting advances in early detection and treatment. The earlier a malignant neoplasm is caught, the more treatment options are available and the better the outcomes tend to be.